MedPath

Effects of Statin on Renal Function in Patients with Chronic Kidney Disease

Phase 4
Conditions
Chronic kidney disease Hypercholesterolemia
Registration Number
JPRN-UMIN000002526
Lead Sponsor
Department of Medical Science and Cardiorenal Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1)patient with less than eGFR 15mL/min/1.73m2 2)Patients meeting the contraindications or relative contraindications for pitavastatin 3)malignant tumor patient and the patient who have an anamnesis within five years 4)patient who developed cerebrovascular disorder within one month 5)patients with hypothyroidism, hereditary muscular disorder (muscular dystrophy), and medicine-related muscle disorder 6)Patients currently taking lipid lowering therapy 7)abnormal glycemia 8)angina 9)Patients participating in other studies 10)Patients ineligible for the study determined by doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percent changes in eGFR from baseline Urinary protein excretion (UACR)
Secondary Outcome Measures
NameTimeMethod
1)Percent changes in TC,LDL-C,HDL-C,TG 2)Percent changes in Glucose,HbA1c, 3)Percent changes in hs-CRP 4)Percent changes in Pentosidine,L-FABP 5)Ambulatory BP monitering,PWV,ABI, central blood pressure
© Copyright 2025. All Rights Reserved by MedPath